Last reviewed · How we verify

NCT03487211: CORTEX

Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia

Completed Phase 2, PHASE3 Last updated 27 February 2020
What this trial tests

Phase 2, PHASE3 trial testing Duloxetine in Fibromyalgia in 200 participants. Completed in 26 February 2020.

Timeline
9 April 2018
Primary endpoint
26 February 2020
26 February 2020

Quick facts

Lead sponsorShaheed Zulfiqar Ali Bhutto Medical University
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment200
Start date9 April 2018
Primary completion26 February 2020
Estimated completion26 February 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Shaheed Zulfiqar Ali Bhutto Medical University

Who can join

Adults 18 to 70, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Duloxetine is FDA approved as pharmacological treatment for Fibromyalgia. The use of SSRIs has been endorsed by the 2013 Canadian guidelines. The data available for Escitalopram as a treatment modality for Fibromyalgia is limited, however small trials have demonstrated its efficacy. No head to head comparisons between escitalopram and duloxetine have been undertaken. We aim to conduct a single blind, randomized control trial to assess the comparative efficacy of duloxetine vs escitalopram in drug naive patients with newly diagnosed Fibromyalgia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Neuro-Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets.
    Guo X, Liu H, Song YJ, Wang JH, et al · · 2026 · cited 2× · PMID 41583906 · DOI 10.1002/mco2.70497

Verify or expand the search:

Other trials of Duloxetine

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Shaheed Zulfiqar Ali Bhutto Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03487211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing